Why the study?
Hormone therapy efficacy after menopause may depend on baseline health status, leading to the hypothesis that preexisting hypertension blunts estradiol's cardiovascular and renal benefits.
Does Estradiol protect against angiotensin II-induced hypertension and associated renal, cardiac, and vascular damage in middle-aged ovariectomized rats?
Population
Female Long-Evans rats ovariectomized at 46 weeks
Comparison
Estradiol vs vehicle with or without angiotensin II infusion
Design
Preclinical animal study
Authors
Loading...
Preexisting hypertension may blunt estradiol effects post-menopause in rats; leaves open human relevance and clinical translation.
Does Estradiol protect against angiotensin II-induced hypertension and associated renal, cardiac, and vascular damage in middle-aged ovariectomized rats?
In a rat model of menopause, preexisting hypertension blunted the protective effects of estradiol, suggesting that cardiovascular health at menopause onset is a critical determinant of hormone therapy efficacy.
Leite et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: